A new group of defibrillatory drugs in the classification of antiarrhythmic agents.
Ventricular antiarrhythmic therapy is aimed traditionally at preventing arrhythmias and ventricular fibrillation. Recently, a new approach has been introduced, where drug therapy facilitates the ability of the heart for spontaneous defibrillation. The chemical features and the electrophysiologic properties are discussed below. The introduction of this new group of defibrillating antiarrhythmic drugs implies the extension of the common classification of antiarrhythmic drugs.
Manoach
M
M
Department of Physiology and Pharmacology, Sackler School of Medicine, Tel Aviv University, Ramat Aviv, Israel.
Varon
D
D
Neuman
M
M
Erez
M
M
D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000145:classification* / Q000627:therapeutic use; D006801:Humans; D014693:Ventricular Fibrillation / Q000188:drug therapy*
D000889:Anti-Arrhythmia Agents